Medical Properties Trust, Inc. Reports Second Quarter Results
- The company's ability to reduce future income tax expense and expand strategic flexibility through the establishment of a REIT structure in the UK is a positive move. The sale of three general acute hospitals for approximately $100 million also reflects the company's strategic decision-making and financial gains.
- None.
Per Share Net Loss of (
-
Net loss of (
) and Normalized Funds from Operations (“NFFO”) of$0.07 for the 2023 second quarter on a per diluted share basis;$0.48 -
Commenced in May rent collections at a newly developed post-acute facility in
California leased to Ernest Health at a total cost of approximately ;$50 million -
Sold in July three general acute hospitals in
Kansas andTexas to Prime Healthcare for roughly ;$100 million - Elected to participate in August as one of seven unrelated initial lenders in Steward Health Care System’s (“Steward”) syndicated asset-backed credit facility; and
-
Established a REIT structure within the
United Kingdom , reducing future expected income tax expense and expanding strategic flexibility.
Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income, and reconciliations of net income to NFFO and AFFO, including per share amounts, all on a basis comparable to 2022 results.
PORTFOLIO UPDATE
During the third quarter, Steward refinanced its asset-backed credit facility five months ahead of the maturity of its previous agreement. The new facility carries a four-year term and provides significant incremental liquidity to Steward. The leaders of the lending group, experienced private credit funds Sound Point Capital Management and Brigade Capital Management, offered MPT the opportunity to participate. After careful consideration of the terms, pricing and security in the form of government and commercial receivables, MPT elected to invest up to
In early August, one of Pipeline Health System’s (“Pipeline”)
The Company has total assets of approximately
OPERATING RESULTS AND OUTLOOK
Net loss for the second quarter ended June 30, 2023 was (
NFFO for the second quarter ended June 30, 2023 was
The Company is narrowing its 2023 calendar estimate of per share net income to
These estimates do not include the effects, among others, of unexpected real estate operating costs, modifications to lease terms, changes in accounting pronouncements, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, changes in income tax rates, interest rate hedging activities, write-offs of straight-line rent and in place lease intangibles, other impairments or other non-recurring/unplanned transactions. These estimates may change if the Company acquires or sells assets in amounts that are different from estimates, market interest rates change, debt is refinanced or repurchased, new shares are issued or repurchased, additional debt is incurred, other operating expenses vary, income from equity investments vary from expectations, or existing leases or loans do not perform in accordance with their terms.
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Tuesday, August 8, 2023 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter ended June 30, 2023. The dial-in numbers for the conference call are 844-481-2836 (
A telephone and webcast replay of the call will be available beginning shortly after the call’s completion. The telephone replay will be available through August 22, 2023 using dial-in numbers 877-344-7529 (
The Company’s supplemental information package for the current period will also be available on the Company’s website in the Investor Relations section.
The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.medicalpropertiestrust.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, future expansion and development activities, and expected financial performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the economic, political and social impact of, and uncertainty relating to, potential impact from health crises (like COVID-19); (ii) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us, especially as a result of the adverse economic impact of the COVID-19 pandemic, and government regulation of hospitals and healthcare providers in connection with same (as further detailed in our Current Report on Form 8-K filed with the SEC on April 8, 2020); (iii) our expectations regarding annual guidance for net income and NFFO per share; (iv) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (v) the nature and extent of our current and future competition; (vi) macroeconomic conditions, such as a disruption of or lack of access to the capital markets or movements in currency exchange rates; (vii) our ability to obtain debt financing on attractive terms or at all, which may adversely impact our ability to pursue acquisition and development opportunities and pay down, refinance, restructure or extend our indebtedness as it becomes due; (viii) increases in our borrowing costs as a result of changes in interest rates and other factors; (ix) international, national and local economic, real estate and other market conditions, which may negatively impact, among other things, the financial condition of our tenants, lenders and institutions that hold our cash balances, and may expose us to increased risks of default by these parties; (x) factors affecting the real estate industry generally or the healthcare real estate industry in particular; (xi) our ability to maintain our status as a REIT for federal and state income tax purposes; (xii) federal and state healthcare and other regulatory requirements, as well as those in the foreign jurisdictions where we own properties; (xiii) the value of our real estate assets, which may limit our ability to dispose of assets at attractive prices or obtain or maintain equity or debt financing secured by our properties or on an unsecured basis; (xiv) the ability of our tenants and operators to operate profitably and generate positive cash flow, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (xv) potential environmental contingencies and other liabilities; (xvi) the risk that the expected sale of three
The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 and as updated in our quarterly reports on Form 10-Q. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | ||||||||||
Consolidated Balance Sheets | ||||||||||
(Amounts in thousands, except for per share data) | ||||||||||
June 30, 2023 | December 31, 2022 | |||||||||
Assets | (Unaudited) | (A) | ||||||||
Real estate assets | ||||||||||
Land, buildings and improvements, intangible lease assets, and other | $ |
13,133,651 |
|
$ |
13,862,415 |
|
||||
Investment in financing leases |
|
1,231,652 |
|
|
1,691,323 |
|
||||
Real estate held for sale |
|
401,125 |
|
|
- |
|
||||
Mortgage loans |
|
299,326 |
|
|
364,101 |
|
||||
Gross investment in real estate assets |
|
15,065,754 |
|
|
15,917,839 |
|
||||
Accumulated depreciation and amortization |
|
(1,251,165 |
) |
|
(1,193,312 |
) |
||||
Net investment in real estate assets |
|
13,814,589 |
|
|
14,724,527 |
|
||||
Cash and cash equivalents |
|
324,050 |
|
|
235,668 |
|
||||
Interest and rent receivables, net |
|
177,643 |
|
|
167,035 |
|
||||
Straight-line rent receivables |
|
779,584 |
|
|
787,166 |
|
||||
Investments in unconsolidated real estate joint ventures |
|
1,487,118 |
|
|
1,497,903 |
|
||||
Investments in unconsolidated operating entities |
|
1,812,150 |
|
|
1,444,872 |
|
||||
Other loans |
|
199,360 |
|
|
227,839 |
|
||||
Other assets |
|
609,881 |
|
|
572,990 |
|
||||
Total Assets | $ |
19,204,375 |
|
$ |
19,658,000 |
|
||||
Liabilities and Equity | ||||||||||
Liabilities | ||||||||||
Debt, net | $ |
10,237,558 |
|
$ |
10,268,412 |
|
||||
Accounts payable and accrued expenses |
|
444,926 |
|
|
621,324 |
|
||||
Deferred revenue |
|
49,766 |
|
|
27,727 |
|
||||
Obligations to tenants and other lease liabilities |
|
157,411 |
|
|
146,130 |
|
||||
Total Liabilities |
|
10,889,661 |
|
|
11,063,593 |
|
||||
Equity | ||||||||||
Preferred stock, |
||||||||||
outstanding |
|
- |
|
|
- |
|
||||
Common stock, |
||||||||||
outstanding - 598,344 shares at June 30, 2023 and 597,476 |
|
598 |
|
|
597 |
|
||||
shares at December 31, 2022 | ||||||||||
Additional paid-in capital |
|
8,547,835 |
|
|
8,535,140 |
|
||||
Retained (deficit) earnings |
|
(241,301 |
) |
|
116,285 |
|
||||
Accumulated other comprehensive income (loss) |
|
6,680 |
|
|
(59,184 |
) |
||||
Total Medical Properties Trust, Inc. Stockholders' Equity |
|
8,313,812 |
|
|
8,592,838 |
|
||||
Non-controlling interests |
|
902 |
|
|
1,569 |
|
||||
Total Equity |
|
8,314,714 |
|
|
8,594,407 |
|
||||
Total Liabilities and Equity | $ |
19,204,375 |
|
$ |
19,658,000 |
|
||||
(A) Financials have been derived from the prior year audited financial statements. |
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES |
|||||||||||||||||
Consolidated Statements of Income |
|||||||||||||||||
(Unaudited) |
|||||||||||||||||
(Amounts in thousands, except for per share data) | For the Three Months Ended | For the Six Months Ended | |||||||||||||||
June 30, 2023 | June 30, 2022 | June 30, 2023 | June 30, 2022 | ||||||||||||||
Revenues | |||||||||||||||||
Rent billed | $ |
247,491 |
|
$ |
241,209 |
|
$ |
495,648 |
|
$ |
504,611 |
|
|||||
Straight-line rent |
|
(39,329 |
) |
|
58,518 |
|
|
17,364 |
|
|
119,562 |
|
|||||
Income from financing leases |
|
68,468 |
|
|
51,873 |
|
|
81,663 |
|
|
103,649 |
|
|||||
Interest and other income |
|
60,765 |
|
|
48,626 |
|
|
92,931 |
|
|
82,204 |
|
|||||
Total revenues |
|
337,395 |
|
|
400,226 |
|
|
687,606 |
|
|
810,026 |
|
|||||
Expenses | |||||||||||||||||
Interest |
|
104,470 |
|
|
87,730 |
|
|
202,124 |
|
|
178,913 |
|
|||||
Real estate depreciation and amortization |
|
364,403 |
|
|
84,334 |
|
|
448,263 |
|
|
169,650 |
|
|||||
Property-related (A) |
|
24,676 |
|
|
21,135 |
|
|
31,786 |
|
|
29,733 |
|
|||||
General and administrative |
|
35,604 |
|
|
38,858 |
|
|
77,328 |
|
|
80,282 |
|
|||||
Total expenses |
|
529,153 |
|
|
232,057 |
|
|
759,501 |
|
|
458,578 |
|
|||||
Other income (expense) | |||||||||||||||||
Gain on sale of real estate |
|
167 |
|
|
16,355 |
|
|
229 |
|
|
467,993 |
|
|||||
Real estate and other impairment charges |
|
- |
|
|
- |
|
|
(89,538 |
) |
|
(4,875 |
) |
|||||
Earnings from equity interests |
|
12,224 |
|
|
14,785 |
|
|
23,576 |
|
|
22,123 |
|
|||||
Debt refinancing and unutilized financing costs |
|
(816 |
) |
|
(619 |
) |
|
(816 |
) |
|
(9,435 |
) |
|||||
Other (including fair value adjustments on securities) |
|
(10,512 |
) |
|
2,031 |
|
|
(15,678 |
) |
|
16,793 |
|
|||||
Total other income (expense) |
|
1,063 |
|
|
32,552 |
|
|
(82,227 |
) |
|
492,599 |
|
|||||
(Loss) income before income tax |
|
(190,695 |
) |
|
200,721 |
|
|
(154,122 |
) |
|
844,047 |
|
|||||
Income tax benefit (expense) |
|
148,262 |
|
|
(10,657 |
) |
|
144,719 |
|
|
(22,036 |
) |
|||||
Net (loss) income |
|
(42,433 |
) |
|
190,064 |
|
|
(9,403 |
) |
|
822,011 |
|
|||||
Net loss (income) attributable to non-controlling interests |
|
396 |
|
|
(467 |
) |
|
160 |
|
|
(733 |
) |
|||||
Net (loss) income attributable to MPT common stockholders | $ |
(42,037 |
) |
$ |
189,597 |
|
$ |
(9,243 |
) |
$ |
821,278 |
|
|||||
Earnings per common share - basic and diluted: | |||||||||||||||||
Net (loss) income attributable to MPT common stockholders | $ |
(0.07 |
) |
$ |
0.32 |
|
$ |
(0.02 |
) |
$ |
1.37 |
|
|||||
Weighted average shares outstanding - basic |
|
598,344 |
|
|
598,827 |
|
|
598,323 |
|
|
598,751 |
|
|||||
Weighted average shares outstanding - diluted |
|
598,344 |
|
|
599,026 |
|
|
598,323 |
|
|
598,979 |
|
|||||
Dividends declared per common share | $ |
0.29 |
|
$ |
0.29 |
|
$ |
0.58 |
|
$ |
0.58 |
|
|||||
(A) Includes |
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | ||||||||||||||||
Reconciliation of Net Income to Funds From Operations | ||||||||||||||||
(Unaudited) | ||||||||||||||||
(Amounts in thousands, except for per share data) |
For the Three Months Ended | For the Six Months Ended | ||||||||||||||
June 30, 2023 | June 30, 2022 | June 30, 2023 | June 30, 2022 | |||||||||||||
FFO information: | ||||||||||||||||
Net (loss) income attributable to MPT common stockholders | $ |
(42,037 |
) |
$ |
189,597 |
|
$ |
(9,243 |
) |
$ |
821,278 |
|
||||
Participating securities' share in earnings |
|
(469 |
) |
|
(345 |
) |
|
(984 |
) |
|
(747 |
) |
||||
Net (loss) income, less participating securities' share in earnings | $ |
(42,506 |
) |
$ |
189,252 |
|
$ |
(10,227 |
) |
$ |
820,531 |
|
||||
Depreciation and amortization |
|
382,244 |
|
|
101,976 |
|
|
484,204 |
|
|
201,435 |
|
||||
Gain on sale of real estate |
|
(167 |
) |
|
(16,355 |
) |
|
(229 |
) |
|
(467,993 |
) |
||||
Real estate impairment charges |
|
- |
|
|
- |
|
|
52,104 |
|
|
- |
|
||||
Funds from operations | $ |
339,571 |
|
$ |
274,873 |
|
$ |
525,852 |
|
$ |
553,973 |
|
||||
Write-off (recovery) of unbilled rent and other |
|
95,642 |
|
|
1,943 |
|
|
135,268 |
|
|
(328 |
) |
||||
Other impairment charges |
|
- |
|
|
- |
|
|
- |
|
|
4,875 |
|
||||
Litigation and other |
|
2,502 |
|
|
- |
|
|
10,228 |
|
|
- |
|
||||
Share-based compensation adjustments |
|
(4,363 |
) |
|
(966 |
) |
|
(4,363 |
) |
|
(966 |
) |
||||
Non-cash fair value adjustments |
|
8,374 |
|
|
(943 |
) |
|
4,253 |
|
|
(8,966 |
) |
||||
Tax rate changes and other |
|
(157,230 |
) |
|
(825 |
) |
|
(164,535 |
) |
|
(825 |
) |
||||
Debt refinancing and unutilized financing costs |
|
816 |
|
|
619 |
|
|
816 |
|
|
9,435 |
|
||||
Normalized funds from operations | $ |
285,312 |
|
$ |
274,701 |
|
$ |
507,519 |
|
$ |
557,198 |
|
||||
Share-based compensation |
|
10,800 |
|
|
11,075 |
|
|
22,629 |
|
|
22,879 |
|
||||
Debt costs amortization |
|
5,203 |
|
|
4,560 |
|
|
10,324 |
|
|
10,173 |
|
||||
Rent deferral, net |
|
2,380 |
|
|
(3,327 |
) |
|
4,793 |
|
|
(7,043 |
) |
||||
Straight-line rent revenue from operating and finance leases |
|
(60,825 |
) |
|
(74,757 |
) |
|
(123,414 |
) |
|
(152,090 |
) |
||||
Adjusted funds from operations | $ |
242,870 |
|
$ |
212,252 |
|
$ |
421,851 |
|
$ |
431,117 |
|
||||
Per diluted share data: | ||||||||||||||||
Net (loss) income, less participating securities' share in earnings | $ |
(0.07 |
) |
$ |
0.32 |
|
$ |
(0.02 |
) |
$ |
1.37 |
|
||||
Depreciation and amortization |
|
0.64 |
|
|
0.17 |
|
|
0.81 |
|
|
0.33 |
|
||||
Gain on sale of real estate |
|
- |
|
|
(0.03 |
) |
|
- |
|
|
(0.78 |
) |
||||
Real estate impairment charges |
|
- |
|
|
- |
|
|
0.09 |
|
|
- |
|
||||
Funds from operations | $ |
0.57 |
|
$ |
0.46 |
|
$ |
0.88 |
|
$ |
0.92 |
|
||||
Write-off (recovery) of unbilled rent and other |
|
0.16 |
|
|
- |
|
|
0.23 |
|
|
- |
|
||||
Other impairment charges |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
||||
Litigation and other |
|
- |
|
|
- |
|
|
0.01 |
|
|
- |
|
||||
Share-based compensation adjustments |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
||||
Non-cash fair value adjustments |
|
0.01 |
|
|
- |
|
|
- |
|
|
(0.01 |
) |
||||
Tax rate changes and other |
|
(0.26 |
) |
|
- |
|
|
(0.27 |
) |
|
- |
|
||||
Debt refinancing and unutilized financing costs |
|
- |
|
|
- |
|
|
- |
|
|
0.02 |
|
||||
Normalized funds from operations | $ |
0.48 |
|
$ |
0.46 |
|
$ |
0.85 |
|
$ |
0.93 |
|
||||
Share-based compensation |
|
0.02 |
|
|
0.02 |
|
|
0.04 |
|
|
0.04 |
|
||||
Debt costs amortization |
|
0.01 |
|
|
0.01 |
|
|
0.02 |
|
|
0.02 |
|
||||
Rent deferral, net |
|
- |
|
|
(0.01 |
) |
|
- |
|
|
(0.01 |
) |
||||
Straight-line rent revenue from operating and finance leases |
|
(0.10 |
) |
|
(0.13 |
) |
|
(0.21 |
) |
|
(0.26 |
) |
||||
Adjusted funds from operations | $ |
0.41 |
|
$ |
0.35 |
|
$ |
0.70 |
|
$ |
0.72 |
|
||||
Notes: (A) Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "Earnings from equity interests" line on the consolidated statements of income.
(B) Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) straight-line rent, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based more on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our infrastructure-type assets generally require longer term leases with annual contractual escalations of base rents, resulting in the recognition of a significant amount of rental income that is not billable/collected until future periods. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity.
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | ||||||||
2023 Guidance Reconciliation | ||||||||
(Unaudited) | ||||||||
2023 Guidance - Per Share(1) | ||||||||
Low | High | |||||||
Net income attributable to MPT common stockholders | $ |
0.33 |
|
$ |
0.37 |
|
||
Participating securities' share in earnings |
|
- |
|
|
- |
|
||
Net income, less participating securities' share in earnings | $ |
0.33 |
|
$ |
0.37 |
|
||
Depreciation and amortization |
|
1.14 |
|
|
1.14 |
|
||
Real estate impairment charges |
|
0.09 |
|
|
0.09 |
|
||
Funds from operations | $ |
1.56 |
|
$ |
1.60 |
|
||
Other adjustments |
|
(0.03 |
) |
|
(0.03 |
) |
||
Normalized funds from operations | $ |
1.53 |
|
$ |
1.57 |
|
||
(1) The guidance is based on current expectations and actual results or future events may differ materially from those expressed in this table, which is a forward-looking statement within the meaning of the federal securities laws. Please refer to the forward-looking statement included in this press release and our filings with the Securities and Exchange Commission for a discussion of risk factors that affect our performance. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230807725046/en/
Drew Babin, CFA, CMA
Senior Managing Director of Corporate Communications
Medical Properties Trust, Inc.
(646) 884-9809
dbabin@medicalpropertiestrust.com
Source: Medical Properties Trust, Inc.
FAQ
What were Medical Properties Trust, Inc.'s net loss and Normalized FFO in the second quarter of 2023?
What key events did Medical Properties Trust, Inc. announce in the press release?
What is the purpose of establishing a REIT structure in the UK for Medical Properties Trust, Inc.?